Lymphoblastic Lymphoma — Trials

Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 37%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05215405	Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL	no longer available	—	—	Kathleen LudwigOTHER	1	Feb 3, 2025	clinicaltrials
NCT03592576	Expanded Access to Navitoclax	no longer available	—	—	AbbVieINDUSTRY	0	May 6, 2024	clinicaltrials